Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT)-Reference-Cited by-同舟云学术

Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT)

Published:2016-05-20 Issue:14 Volume:122 Page:2242-2250
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Wong Anthony C.¹,Watson Sydeaka P.²,Pitroda Sean P.¹,Son Christina H.¹,Das Lauren C.¹,Stack Melinda E.³,Uppal Abhineet³,Oshima Go³,Khodarev Nikolai N.¹⁴,Salama Joseph K.⁵,Weichselbaum Ralph R.¹⁴,Chmura Steven J.¹

Affiliation:

1. Department of Radiation and Cellular Oncology; the University of Chicago; Chicago Illinois

2. Department of Public Health Sciences; the University of Chicago; Chicago Illinois

3. Department of Surgery; the University of Chicago; Chicago Illinois

4. Ludwig Center for Metastasis Research; the University of Chicago; Chicago Illinois

5. Department of Radiation Oncology; Duke University; Durham North Carolina

Funder

Ludwig Center for Metastasis Research, University of Chicago Research Center

The Chicago Tumor Institute Center for Radiation Therapy

University of Chicago Comprehensive Cancer Center

University of Chicago-National Cancer Institute/National Clinical Trials Network

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference40 articles.

1. Oligometastases;Hellman;J Clin Oncol.,1995

2. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases;Pastorino;J Thorac Cardiovasc Surg.,1997

3. Liver resection for colorectal metastases;Fong;J Clin Oncol.,1997

4. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients;Jong;Ann Surg.,2009

5. Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease;Carpizo;Ann Surg Oncol.,2009

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OligoM-Cancer: A multidimensional information platform for deep phenotyping of heterogenous oligometastatic cancer;Computational and Structural Biotechnology Journal;2024-12

2. Oligometastasierung – Hype oder Hoffnung?;Forum;2024-08-07

3. SBRT in Lymph-Nodal Oligometastases from Prostate Cancer: Different Outcomes between Pelvic and Para-Aortic Disease;Journal of Clinical Medicine;2024-06-03

4. Definitive results of a prospective non-randomized phase 2 study on stereotactic body radiation therapy (sbrt) for medically inoperable lung and liver oligometastases from breast cancer;Radiotherapy and Oncology;2024-06

5. Survival Benefit of Synchronous Lenvatinib Combined PD-1 Inhibitors for Advanced Hepatocellular Carcinoma Beyond Oligometastasis;ImmunoTargets and Therapy;2024-06